Berenberg upgrades Eli Lilly ( $LLY) to Buy and raises its price target to $1,400 from $1,200, suggesting more than 21% upside from current levels. Eli Lilly's Zepbound and Mounjaro established leading positions in obesity and diabetes treatment. $SPY $XLV $JNJ